Research Focus

Former Employee. Medicine; Research Stdy Specialist

Recent additions – View all

1. Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies

   Journal Article

   Voss, M. H.; Bastos, D. A.; Karlo, C. A.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Hsieh, J. J.; Molina, A. M.; Patil, S.; Motzer, R. J.
   Annals of Oncology (2014)

   Fulltext@MSK | Save
2. Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events

   Meeting Abstract

   Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
   Journal of Clinical Oncology (2013)

   Fulltext@MSK | Save
3. mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)

   Meeting Abstract

   Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
   Journal of Clinical Oncology (2013)

   Fulltext@MSK | Save